BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
MDM2
,
Metabolism of xenobiotics
,
HIV infection
,
Prostate
,
Laryngoscope
,
Quercetin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
benzomorphans
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
OPRM1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
Mu opioid receptor
morphine receptor activity
negative regulation of Wnt protein secretion
Opioid receptor
negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Design, synthesis, in vitro evaluation, and molecular modeling studies of N-substituted benzomorphan…
LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief.
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5…
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased…
Differential scanning calorimetry approach to investigate the transfer of the multitarget opioid ana…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for benzomorphans
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ